Bloomberg reports today that Johnson & Johnson intends to take its Linx reflux management system off the market outside the U ...

Johnson & Johnson, which said it made the decision based on a market assessment, did not specify the markets it is leaving or ...

Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move ...

Johnson & Johnson will halt international sales of its Linx reflux device, sparking concern among surgeons over limited options for GERD patients.

J&J: Johnson & Johnson announced the withdrawal of its LINX Reflux Management System in selected markets outside the U.S. due ...

A UK-wide research team, led by the University of Oxford's Nuffield Department of Surgical Sciences, has launched a major international study to improve surgical treatment for people suffering from ...

Johnson & Johnson (JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, ...

The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and ...

A major international study has been launched to improve surgical treatment for people suffering from acid reflux. The University of Oxford’s Nuffield Department of Surgical Sciences is leading the ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Johnson & Johnson (NYSE:JNJ) announced plans to remove its LINX Reflux Management System from markets outside the United ...

Johnson & Johnson is withdrawing the Linx Reflux Management System from markets outside the U.S., citing a commercial decision unrelated to the ...